Recombinant ferritins for multimodal nanomedicine.

Yihao Li, Haoyu Gao, Eugenie Nepovimova, Qinghua Wu, Vojtech Adam, Kamil Kuca

Journal: Journal of enzyme inhibition and medicinal chemistry 2023;38(1):2219868

PMID: 37263586

Abstract

In all living organisms, ferritins are a group of proteins important for maintaining iron homeostasis. Increasing amount of studies has shown that recombinant ferritins can be widely used in multimodal nanomedicine, especially for anticancer treatment and vaccination. Recombinant particles prepared by fusing viral proteins and ferritin subunits produce a better immune response and higher antibody titres. Moreover, actively-targeted ferritin nanoparticles can recognise receptors and deliver natural or chemical drugs specifically to the tumour tissue. In addition, ferritin-linked or loaded with contrast agents or fluorescent dyes can be used as multimodal particles useful cancer theranostics. In this review, we fully summarised the unitisation of recombinant ferritins in multimodal nanomedicine. The research progress of using recombinant ferritins as nanovaccines, nanozymes, and bioengineered nanocarriers for targeted therapy and bioimaging is emphasised.

Address: College of Life Science, Yangtze University, Jingzhou, China.; Department of Chemistry, Faculty of Science, University of Hradec Kralove, Hradec Králové, Czech Republic.; College of Life Science, Yangtze University, Jingzhou, China.; Department of Chemistry, Faculty of Science, University of Hradec Kralove, Hradec Králové, Czech Republic.; Department of Chemistry and Biochemistry, Mendel University in Brno, Brno, Czech Republic.; Department of Chemistry, Faculty of Science, University of Hradec Kralove, Hradec Králové, Czech Republic.; Biomedical Research Center, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.